PharmEvo’s WHO Prequalification: ushering a new era in Pakistan Economic Development.

WHO prequalification can enhance a country’s ability to export pharmaceutical products to international markets. The prequalification status serves as a recognized stamp of approval, giving confidence to other countries and organizations that the products meet high-quality standards. This expanded market access can lead to increased export revenues, contributing positively to the country’s economy.

WHO-prequalified products are often more likely to receive international cooperation. Donors and international organizations may prioritize countries that can demonstrate a commitment to providing high-quality healthcare products, leading to increased support for health programs and infrastructure development.

Having WHO-prequalified products enhances a country’s reputation and credibility in the global pharmaceutical arena. This positive image can attract collaborations, partnerships, and joint ventures with international organizations and pharmaceutical companies, contributing to the country’s economic growth.

Nadeem Rehmat Message (please add NR’s Picture)

COO PharmEvo

A New Milestone for PharmEvo

Dear Colleagues,

I am humbled to share with all of you that after years of hard work, dedication, and meticulous attention to quality, we have achieved a significant milestone that will undoubtedly shape the future of our organization. PharmEvo has been granted the prestigious WHO Prequalification status.

WHO works with countries to help them ensure that people have equitable access to affordable medicines of assured quality, with this achievement, PharmEvo will be in a position to collaborate with WHO, Unicef and several other global donner and procurement agencies towards common goal of equitable, affordable and quality medicines for everyone.

Obtaining the WHO Pre-Qualification status is no small feat. It requires meeting the highest standards of quality, safety, and efficacy set by the World Health Organization. This recognition not only validates our products but also opens up new avenues for growth and opportunities to make a positive impact on global health.

I would like to express my deepest gratitude to each member of our team for their hard work, expertise, and unwavering dedication throughout this journey. Without your commitment to excellence and your relentless pursuit of quality, this milestone would not have been possible.

Moving forward, we must continue to uphold the standards that have earned us this prestigious recognition. Let us remain focused on maintaining and improving our quality management systems, ensuring compliance with regulatory requirements, and consistently delivering safe and effective medicines.

Once again, congratulations to each and every one of you for this remarkable achievement. Together, we have reached a new pinnacle in our journey, and I am confident that the future holds even greater success for our organization and country.

I remain thankful to all of you for your unwavering support

Thanks & Regards,

Nadeem Rehmat

Chief Operating Officer

WHO Prequalification – A Shared Triumph of Collective Efforts

This success is a reflection of the hard work and commitment of every Evodian at the Plant. The level of teamwork displayed throughout this project has been nothing short of exceptional.

“Today, we stand together in triumph as a team. The journey to this achievement was challenging, but your collective efforts have made it a resounding success.

About Author